Author

Timothy J. T. Chevassut

Observed names: CHEVASSUT T, Chevassut TJ, Chevassut Timothy, Chevassut, Timothy, T Chevassut, T J Chevassut, T. Chevassut, T. J. Chevassut, T.J.T. Chevassut, Tim Chevassut, Timothy Chevassut, Timothy Chevassut (4462168), Timothy J T Chevassut, Timothy J. Chevassut, Timothy J.T. Chevassut, Timothy JT Chevassut, Timothy James, Timothy James Telfer Chevassut

Institutions: Brighton and Sussex Medical School, University of Sussex, University Hospitals Sussex NHS Foundation Trust, Brighton and Sussex University Hospitals NHS Trust

Observed institutions: Brighton and Sussex Medical School, Beth Israel Deaconess Medical Center, Harvard University, University of Sussex, King's College London, Western General Hospital, Royal Sussex County Hospital, University Hospitals Sussex NHS Foundation Trust, Brighton and Sussex University Hospitals NHS Trust, University of Brighton, University of Edinburgh

ORCID: 0000-0001-8672-1906

Observed ORCID: 0000-0001-8672-1906

OpenAlex ID: A5090297765

Severe Global DNA Hypomethylation Blocks Differentiation and Induces Histone Hyperacetylation in Embryonic Stem Cells

2004 · Melany Jackson, Anna Krassowska, et al. · Molecular and Cellular Biology · 361

Comment on " 'Stemness': Transcriptional Profiling of Embryonic and Adult Stem Cells" and "A Stem Cell Molecular Signature" (I)

2003 · Nicolas O. Fortunel, Hasan H. Otu, et al. · Science · 338

Von Willebrand factor (vWF): marker of endothelial damage and thrombotic risk in COVID-19?

2020 · Eleni E Ladikou, Helena Sivaloganathan, et al. · Clinical Medicine · 144

Identification of circulating microRNAs as diagnostic biomarkers for use in multiple myeloma

2012 · C I Jones, M V Zabolotskaya, et al. · British Journal of Cancer · 138

DOT1L as a therapeutic target for the treatment of DNMT3A-mutant acute myeloid leukemia

2016 · Rachel E. Rau, Benjamin A. Rodriguez, et al. · Blood · 133

The Epigenetic Landscape of Acute Myeloid Leukemia

2014 · Emma Conway O’Brien, Steven Prideaux, et al. · Advances in Hematology · 117

The Genetic Architecture of Multiple Myeloma

2014 · Steven M. Prideaux, Emma Conway O'Brien, et al. · Advances in Hematology · 117

BRD 4 associates with p53 in DNMT 3A‐mutated leukemia cells and is implicated in apoptosis by the bromodomain inhibitor JQ 1

2013 · Helen Jayne Susan Stewart, Gillian Abigail Horne, et al. · Cancer Medicine · 93

Doubts concerning the recently reported human neutrophil lifespan of 5.4 days

2011 · Paul S. Tofts, Timothy Chevassut, et al. · Blood · 93

IRF4 in multiple myeloma—Biology, disease and therapeutic target

2018 · Alessandro Agnarelli, Tim Chevassut, et al. · Leukemia Research · 77

BRD4-mediated repression of p53 is a target for combination therapy in AML

2021 · Anne-Louise Latif, Ashley Newcombe, et al. · Nature Communications · 76

Targeting SHP-1, 2 and SHIP Pathways: A Novel Strategy for Cancer Treatment?

2018 · Wolfram C.M. Dempke, Peter Uciechowski, et al. · Oncology · 76

COVID‐19 mortality in patients on anticoagulants and antiplatelet agents

2020 · Helena Sivaloganathan, Eleni E Ladikou, et al. · British Journal of Haematology · 75

Thrombotic risk in COVID-19: a case series and case–control study

2020 · Simon M Stoneham, Kate M Milne, et al. · Clinical Medicine · 75

The 3' to 5' Exoribonuclease DIS3: From Structure and Mechanisms to Biological Functions and Role in Human Disease

2015 · Sophie Robinson, Antony Oliver, et al. · Biomolecules · 75

Acute Myeloid Leukaemia in Its Niche: the Bone Marrow Microenvironment in Acute Myeloid Leukaemia

2020 · E. E. Ladikou, H. Sivaloganathan, et al. · Current Oncology Reports · 74

RETRACTED: Autoimmunity as the Consequence of a Spontaneous Mutation in Rasgrp1

2003 · Katrin Layer, Guosheng Lin, et al. · Immunity · 74

Epigenetic Guardian: A Review of the DNA Methyltransferase DNMT3A in Acute Myeloid Leukaemia and Clonal Haematopoiesis

2017 · Sabah F. Chaudry, Timothy J. T. Chevassut · BioMed Research International · 69

Dissecting the role of the CXCL12/CXCR4 axis in acute myeloid leukaemia

2020 · Eleni E Ladikou, Timothy Chevassut, et al. · British Journal of Haematology · 63

Haematology patients and the internet – The use of on-line health information and the impact on the patient–doctor relationship

2014 · Tom Rider, Muzaffar Malik, et al. · Patient Education and Counseling · 55

Nanog Requires BRD4 to Maintain Murine Embryonic Stem Cell Pluripotency and Is Suppressed by Bromodomain Inhibitor JQ1 Together with Lefty1

2014 · Gillian A. Horne, Helen J.S. Stewart, et al. · Stem Cells and Development · 53

Randomised open-label trial comparing intravenous iron and an erythropoiesis-stimulating agent versus oral iron to treat preoperative anaemia in cardiac surgery (INITIATE trial)

2022 · Robert Kong, Nevil Hutchinson, et al. · British Journal of Anaesthesia · 51

The hypomethylating agent Decitabine causes a paradoxical increase in 5-hydroxymethylcytosine in human leukemia cells

2015 · Basudev Chowdhury, Andrew McGovern, et al. · Scientific Reports · 46

TLR9 expression in chronic lymphocytic leukemia identifies a promigratory subpopulation and novel therapeutic target

2021 · Emma Kennedy, Eve Coulter, et al. · Blood · 44

Chronic Lymphocytic Leukaemia in 2020: the Future Has Arrived

2020 · Kate Milne, Beattie Sturrock, et al. · Current Oncology Reports · 33

Works count: 123

Citation count: 3,150

H-index: 29

I10-index: 49